Skip to NavigationSkip to content

medicine

One third of Brits stockpile drugs

A third (33%) of brits stockpile medicines, according to new research from Co-op Health.

One in three British people never get rid of leftover medicines while another third have used medicines past their expiry date.

Of those who admitted to using out-of-date medicines almost half (48%) said they did not realise the medicines had expired, one quarter (25%) presumed it would still be safe to take, and more than a tenth (13%) bought the medicines before they needed to use them.

NHS Confederation chief says news of Brexit extension is a relief

Niall Dickson, the Chief Executive of the NHS Confederation, has said news of the decision to extend the Brexit deadline to the 31st October had come as a ‘relief’.

However, Dickson, who co-chairs the Brexit Health Alliance, called for an end to the ‘circus of uncertainty’ surrounding the UK’s exit from the European Union.

Sunovion CMO Dr Antony Loebel made company's new CEO

Published on: 05/03/19

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr Antony Loebel will succeed Nobuhiko Tamura who has headed the company since 2014.

UK-Japan partnership to see collaboration on incurable diseases, green technology and AI

A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into chronic conditions - such as diabetes, heart disease and arthritis - green technology and AI.

The collaboration, announced by British Prime Minister Theresa May, Business Secretary Greg Clark and Japanese Prime Minister Shinzo Abe, will see £30 million invested into a new partnership aimed at promoting technology and innovation in both Britain and Japan.

Government choose England top pharmacist to address overprescribing and polypharmacy

England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS.

The move comes after Health Secretary Matt Hancock announced that the Government would be looking into overprescribing and ‘problematic polypharmacy’ – the problem of patients taking multiple medicines unnecessarily.

Anti-vaxxers: Vaccines in the age of populism

Published on 06/11/18 at 09:20am

Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss looks into the roots of the anti-vaccine movement and asks what might be done to heal the wound

Amgen slashes price of cholesterol drug Repatha by 60%

American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%.

The move, which is intended to boost sales, has seen Repatha’s list price drop from $14,000 to $5,850.

Murdo Gordon EVP Global Commercial Operations at Amgen suggested that the price cut, “is clearly focused on helping patients afford the medicine at the pharmacy counter.”

He added that the drug needed to be affordable for those on Medicare, the US government’s health plan for seniors.

New 'pen' device identifies cancerous tissue in just ten seconds

Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous tissue in just ten seconds with 96% accuracy, claiming it could speed up tumour removal with greater safety and precision.

Anti-HIV drug PrEP proves safety in gay and bisexual adolescents

A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead's Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects against the human immunodeficiency virus (HIV), is safe to be used by gay and bisexual adolescent men. This follows the treatment’s proven efficacy and safety in adult patients, where it was found to reduce the risk of infection by more than 90%, leading to its approval by the FDA in 2012.

Top Ten most popular articles on Pharmafile.com this week

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its multiple sclerosis drug after seven years.

Also big news was the release of a government commissioned sector report authored by Sir John Bell, Professor of medicine at the University of Oxford, which sets out how life sciences can form a core part of the UK economy as the UK's divorce from the EU nears.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches